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Human neutrophils are rescued from apoptosis following incubation with once-washed, fibroblast-derived
Toxoplasma gondii tachyzoites. Both infected and uninfected neutrophils are rescued, implicating a soluble
mediator. In this study we investigated the origin and identity of this soluble mediator. Neutrophils were
incubated either with purified tachyzoites or with conditioned medium derived from T. gondii-infected human
fibroblasts. Conditioned medium was found to be a potent stimulus that delayed neutrophil apoptosis up to
72 h, whereas purified and extensively washed tachyzoites had no effect. Delayed apoptosis correlated with
up-regulation of the neutrophil antiapoptotic protein, Mcl-1, and the neutrophil interleukin 3 receptor 
subunit (IL-3R), suggesting a role for granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-
CSF and granulocyte colony-stimulating factor (G-CSF) were measurable in conditioned medium by enzyme-
linked immunosorbent assay. Neutralizing antibodies to GM-CSF and G-CSF were additive in abrogating
delayed neutrophil apoptosis induced by conditioned medium. Inhibitors of Src family tyrosine kinases, Gi
proteins, phosphatidylinositol 3-kinase, p44erk1 and p42erk2 mitogen-activated protein kinases, and Jak2 ki-
nases partially attenuated the effect of conditioned medium, consistent with a role for G-CSF and/or GM-CSF.
Hence, delayed neutrophil apoptosis is mediated by GM-CSF and G-CSF secreted by T. gondii-infected human
fibroblasts. This enhanced neutrophil survival may contribute to the robust proinflammatory response elicited
in the T. gondii-infected host.
Toxoplasma gondii, the major cause of central nervous sys-
tem infection in those with AIDS and congenital diseases, is
acquired by ingestion of cysts or oocysts or by transplacental
transmission. In the United States, approximately 10 to 67% of
individuals over 50 years of age have serologic evidence of
infection (30, 37). Acute toxoplasmosis is characterized by
intracellular growth of the rapidly dividing tachyzoite in a va-
riety of host organs, both hemopoietic and nonhemopoietic.
The survival of both the host and the parasite is dependent on
some of these tachyzoites becoming encysted as slowly dividing
bradyzoites in brain and muscle, while the remaining
tachyzoites are eliminated (30). The mechanism that clears the
tachyzoites from infected tissues involves both an innate acute
inflammatory response and an antigen-specific inflammatory
response (20, 60). Neutrophil extravasation from peripheral
blood into infected tissue is one of the earliest responses dur-
ing innate immunity. Neutrophils are the most numerous leu-
kocyte in peripheral blood (60%) and the most short lived.
They are programmed to undergo apoptosis within 24 h of
leaving the bone marrow and entering the circulation and the
tissues (47). More than 10 billion peripheral blood neutrophils
are replaced every day from stores of mature neutrophils in the
bone marrow (14). Neutrophil apoptosis is thought to be cen-
tral to either resolution or persistence of an inflammatory
state, since apoptotic neutrophils become nonfunctional and
are phagocytosed by tissue macrophages (46, 48, 57). Recent
studies have suggested that neutrophils may play an important
role in the acute innate response to T. gondii (7, 31, 49, 51).
When incubated with tachyzoites in vitro, human neutrophils
can lyse many extracellular parasites (20). Nevertheless, as we
have reported recently (11), undamaged toxoplasmas enter
neutrophils by active penetration, evading phagocytic path-
ways. Neutrophils are unable to kill these intracellular
tachyzoites, although they can retard their division time from
the usual rapid 6- to 8-h cycle to a slower 24-h cycle (11). In
these studies we observed that neutrophils incubated with fi-
broblast-derived tachyzoites in vitro survived, whereas neutro-
phils incubated with medium became apoptotic. The objective
of the present study was to determine how neutrophil apopto-
sis was attenuated. We report that this attenuation is mediated
by both granulocyte colony-stimulating factor (G-CSF) and
granulocyte-macrophage colony-stimulating factor (GM-CSF)
secreted by toxoplasma-infected fibroblasts.
MATERIALS AND METHODS
Neutrophil isolation. Endotoxin-free reagents and disposable plasticware were
used in all experiments. Neutrophils were isolated from fresh heparinized blood
from healthy human volunteers. Erythrocytes were removed by Dextran sedi-
mentation. Dextran (6% in saline; T500; Amersham Pharmacia Biotech Inc.,
Piscataway, N.J.) was added to blood at a ratio of 1:9 (vol/vol) at 1 g for 30 min
at room temperature. The leukocyte-rich plasma above the sedimented erythro-
cytes was removed and overlaid onto a two-step gradient comprised of 1.07 g of
Ficoll-Hypaque (Winthrop Laboratories, New York, N.Y.)/ml underlaid with
1.095 g of OptiPrep (Accurate Chemical & Scientific Corp., Westbury, N.Y.)/ml
in the ratio 2:1:1 (vol/vol/vol). After centrifugation (500  g for 20 min), the
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neutrophil layer was removed from the interphase between the Ficoll-Hypaque
and the Optiprep and washed twice in RPMI 1640 containing 25 mM HEPES
buffer with L-glutamine (Gibco BRL, Grand Island, N.Y.). Cells were 99%
polymorphonuclear (3 to 5% eosinophils) and 1% mononuclear (lymphocytes
and monocytes) as determined from Diff-Quik (VWR Scientific Products, Bos-
ton, Mass.) stained cytospins (100,000 cells centrifuged for 5 min at 700 rpm
using a Shandon Cytospin 3 instrument (Shandon Inc., Pittsburgh, Pa.). Neutro-
phils were resuspended to 106/ml in RPMI supplemented with gentamicin sulfate
(50 g/ml; United States Biochemical Corp., Cleveland, Ohio) and 10% (vol/vol)
heat-inactivated fetal bovine serum (endotoxin-low; HyClone Laboratories, Inc.,
Logan, Utah). Cell viability was determined for all experiments by fluorescence
microscopy of neutrophils stained with fluorescein diacetate (7.5 g/ml) and
propidium iodide (PI) (2.5 g/ml) and was always 97%. Contaminating eryth-
rocytes that did not pass through the OptiPrep gradient were not lysed.
Parasites. Human foreskin fibroblasts, maintained for up to 35 generations in
minimal essential medium with Earle’s salts and L-glutamine (Gibco BRL) sup-
plemented with antibiotic-antimycotic solution (Gibco BRL), were used as a
source of T. gondii (PLK strain) tachyzoites and of conditioned medium. Me-
dium from confluent cultures of fibroblasts in 25-cm2 flasks was replaced, and
approximately 400,000 tachyzoites were added. Two days later, medium contain-
ing egressed parasites was removed and passed through a 3-m-pore-size Nucle-
pore polycarbonate filter (Whatman Inc., Clifton, N.J.) to separate fibroblast
debris from egressed toxoplasmas. Filtrate was centrifuged at 900  g for 10 min
to pellet parasites. Parasites were resuspended in fresh medium and used in
experiments (see Fig. 1 to 3). In the remaining experiments, particulates were
removed from the supernatant from this first centrifugation step by passage
through a 0.22-m-pore-size filter, and the resultant filtrate is termed “condi-
tioned medium from infected fibroblasts.” The pelleted tachyzoites from the first
centrifugation step were resuspended in 300 times their pelleted volume and
then centrifuged at 900  g for 10 min. This washing step was repeated a total
of four times. The final tachyzoite pellet (washed tachyzoites) was resuspended
in a volume of fresh medium equivalent to the volume of medium containing
egressed parasites that was first removed from the flask of infected fibroblasts.
Medium removed from fibroblasts that had been cultured for 2 days without
parasites (conditioned medium from uninfected fibroblasts) was processed in a
way identical to processing of conditioned medium from infected fibroblasts.
Fibroblasts were never removed from flasks by scraping.
Assessment of apoptosis. Neutrophils (5  105 in 500 l) in 24-well tissue
culture plates were treated with medium or stimulus for 18 h at 37°C in a CO2
incubator. In some experiments Diff-Quik-stained cytospin preparations of neu-
trophils were scored for morphological changes characteristic of apoptosis (de-
creased size, nuclear condensation). At least 300 cells per slide were counted at
magnification 1,000. For other experiments, stimulated cells were stained with
green fluorescent protein (GFP)-annexin V and PI as described previously (21).
Briefly, 300,000 cells were pelleted and resuspended in 100 l of GFP-annexin
(3.5 g/ml in RPMI supplemented to a total calcium concentration of 2 mM) and
then incubated for 10 min on ice. A further 100 l of PI (2 g/ml in RPMI) was
added, and cells were analyzed immediately by flow cytometry. Ten thousand
events per sample were acquired. GFP-annexin was obtained from J. Ernst
(Division of Infectious Diseases, San Francisco General Hospital, and University
of California, San Francisco, Calif.). Annexin V binds to phosphatidylserine that
is expressed in the outer leaflet of the phospholipid bilayer as a consequence of
apoptosis and necrosis. Cells that are late apoptotic or early necrotic will lose
membrane integrity and stain with both GFP-annexin and PI. Cells that retain
membrane integrity, including viable and early-apoptotic cells, will not take up
PI. Therefore, the combined use of GFP-annexin and PI can distinguish between
early-apoptotic and late-apoptotic or necrotic cells.
SDS-PAGE and Western blotting. Neutrophils (2 107/3 ml of medium) were
incubated in polypropylene tubes at 37°C with or without once-washed, fibro-
blast-derived tachyzoites for various times. Whole-cell extracts were prepared by
boiling pelleted cells for 5 min in sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) reducing sample buffer (62.5 mM Tris-HCl [pH
6.8], 1% SDS, 1% -mercaptoethanol, 10% glycerol, 0.5% bromophenol blue).
Proteins from extracts (5  105 cell equivalents per lane) were resolved by
electrophoresis on SDS–10% PAGE gels and then transferred (120 V for 1 h) to
nitrocellulose membranes (Bio-Rad Laboratories, Hercules, Calif.). Membranes
were stained with Ponceau S (0.2% in 3% trichloroacetic acid) and scanned, and
protein levels in each lane were compared to ensure equal protein loading per
lane. Membranes were rinsed in phosphate-buffered saline (PBS) to remove the
stain, and nonspecific binding sites were blocked with 5% nonfat dry milk (Bio-
Rad Laboratories) in PBS and then probed with primary antibodies (1:1,000
dilution in PBS; polyclonal antibodies to Mcl-1 [S-19] and Bcl-2 [N-19] were from
Santa Cruz Biotechnology, Inc., Santa Cruz, Calif.). Detection of antigen-anti-
body complexes was performed by enhanced chemiluminescence (BM chemilu-
minescence Western blotting kit [mouse/rabbit]; Boehringer Mannheim, Berke-
ley, Calif.). For confirmation of specificity of the anti-Mcl-1 antibody, whole-cell
extracts of cells that expressed high levels of Mcl-1 were obtained from R. Craig,
(Department of Pharmacology, Dartmouth Medical School, Hanover, N.H.) and
run on each gel as a positive control for Mcl-1 detection. The anti-Mcl-1 antibody
detected the same band (40 kDa) in whole-cell extracts of both these control
cells and neutrophils.
Flow cytometry and ELISA. Neutrophils (2.5 105/250 l in 96-well U-bottom
polypropylene plates; Costar, Corning, N.Y.) were washed and resuspended in 40
l of ice-cold human -globulin (from Cohn fraction II, III; Sigma Chemical Co.,
St. Louis, Mo.; 6 mg/ml in PBS containing 1% bovine serum albumin and 0.1%
sodium azide) to block nonspecific binding of antibodies to the Fc region of
neutrophil FcRI. Saturating concentrations of antibodies against human inter-
leukin 3 receptor  subunit (IL-3R) (phycoerythrin–anti-human CD123; Bec-
ton Dickinson, San Jose, Calif.) or isotype control antibodies (phycoerythrin-
mouse immunoglobulin G1 [IgG1] isotype control immunoglobulin; BD
PharMingen, San Diego, Calif.) were added (volume, 20 l), and cells were
incubated on ice for 45 min and then washed. Stained neutrophils were examined
by flow cytometry and were gated for viable cells by forward and side scatter
criteria. The OptEIA human GM-CSF ELISA set was from BD Pharmingen.
The G-CSF and gamma interferon (IFN-) ELISA Duosets were from R&D
Systems, Minneapolis, Minn. The G-CSF and GM-CSF ELISA assays were
calibrated with human reference GM-CSF and G-CSF obtained from C. W.
Reynolds (Biological Response Modifiers Program, National Cancer Institute-
Frederick Cancer Research and Development Center, Frederick, Md.).
Neutralization and inhibitor experiments. Neutralizing or isotype control an-
tibodies were preincubated with 350 pg of G-CSF/ml, 10 pg of GM-CSF/ml, or
a 1:80 dilution of conditioned medium from infected fibroblasts, for 1 h at 37°C,
and then neutrophils (5  105 in 500 l in a 24-well tissue culture plate) were
stimulated for a further 18 h and apoptosis was determined. Human G-CSF
(filgrastim neupogen) was obtained from Amgen, Inc., Thousand Oaks, Calif..
Human GM-CSF (sargramostim leukine) was from Immunex Corp., Seattle,
Wash. Anti-human GM-CSF and anti-human G-CSF neutralizing antibodies and
normal goat IgG (isotype control) were from R&D Systems Inc.. Neutrophils
were also incubated with pharmacological inhibitors for 1 h at 37°C before and
during stimulation with a 1:80 final dilution of conditioned medium from in-
fected fibroblasts, a mixture of 2 ng of G-CSF/ml and 50 pg of GM-CSF/ml, or
medium alone. Apoptosis was measured by GFP-annexin and PI staining 18 h
poststimulation. Inhibitors were titrated in preliminary experiments to determine
the optimal inhibitory dose. Pertussis toxin (Gi protein inhibitor [1, 42]) was
obtained from Sigma Chemical Co.. PP2 (Src family tyrosine kinase inhibitor
[45]), PD098059 (ERK inhibitor [18, 36]), wortmannin (phosphatidylinositol
3-kinase inhibitor [19]), SB203580 (p38 MAP kinase inhibitor [54]), and AG490
(Janus kinase inhibitor [38]) were from Calbiochem, La Jolla, Calif. Where
necessary, inhibitors were diluted in dimethyl sulfoxide (Sigma Chemical Co.).
Diluted dimethyl sulfoxide had no effect on spontaneous neutrophil apoptosis
(data not shown).
RESULTS
Incubation of neutrophils with fibroblast-derived toxoplas-
mas delays spontaneous neutrophil apoptosis, and this effect
is dose dependent. After leaving the bone marrow, peripheral
blood neutrophils are programmed to die within 24 h as a
result of constitutive and spontaneous apoptosis. Neutrophils
maintained in culture in vitro undergo the same fate (48).
Apoptosis is characterized by cell shrinkage, blebbing of the
plasma membrane, and nuclear condensation (58). When
freshly isolated neutrophils were incubated overnight with me-
dium, more than 75% of these cells underwent spontaneous
apoptosis (Fig. 1A). To determine the effect of T. gondii on
neutrophil apoptosis and intracellular infection, extracellular
parasites that had recently egressed from infected human fi-
broblasts were washed once, resuspended in fresh medium,
and coincubated with freshly isolated neutrophils at various
multiplicities of infection for 18 h. Cytospin preparations of
neutrophils were scored for apoptosis and for intracellular
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infection. Figure 1B shows that incubation of neutrophils with
once-washed, fibroblast-derived tachyzoites attenuated spon-
taneous apoptosis. To determine whether apoptosis was com-
pletely inhibited, neutrophils were incubated with tachyzoites
and apoptosis was determined by annexin and PI staining until
72 h postinfection. Eighty, forty-six, and six percent neutrophils
remained viable at 24, 48, or 72 h postinfection, respectively,
suggesting that apoptosis was delayed rather than completely
inhibited. Both delayed neutrophil apoptosis and neutrophil
infection were dose dependent (Fig. 2). Even at a multiplicity
of infection of 4:1, only 20% of neutrophils became infected
and these neutrophils were rarely apoptotic. Moreover, for
each multiplicity of infection, apoptosis was delayed for both
infected and uninfected neutrophils. For example, at a para-
site-to-neutrophil ratio of 1:1, although only 6% of neutrophils
were infected, 36% fewer neutrophils (from 77 to 41%) were
apoptotic compared to uninfected neutrophils (Fig. 2).
The delay in neutrophil apoptosis following fibroblast-de-
rived toxoplasma infection correlates with transiently in-
creased levels of the antiapoptotic protein Mcl-1. Neutrophil
survival has been shown to be concomitant with the up-regu-
lation of the antiapoptotic protein Mcl-1 but not Bcl-2 (39).
mcl-1 is an early response gene whose up-regulation can result
in increased Mcl-1 expression 3 to 5 h after stimulation (12,
59). Mcl-1 expression has also been shown to be associated
with T. gondii rescue of the human cell lines HL-60 and U937
from apoptosis (28). To examine whether tachyzoites may
stimulate Mcl-1 up-regulation in neutrophils, neutrophils were
incubated with medium or with once-washed fibroblast-derived
tachyzoites for various times. Proteins from whole-cell extracts
were resolved by SDS-PAGE, transferred to nitrocellulose
membranes, and immunoblotted with antibodies specific for
Mcl-1 or Bcl-2. Immunoblots with anti-Mcl-1 antibody de-
tected strong signals for neutrophils incubated with tachyzoites
compared to untreated neutrophils, especially at 4 h postinfec-
tion (Fig. 3). The Mcl-1 signal in untreated neutrophils was less
apparent after 9 and 19 h in culture, suggesting the down-
regulation of Mcl-1 during spontaneous apoptosis. Bcl-2 ex-
FIG. 1. Incubation with once-washed, fibroblast-derived toxoplas-
mas delays spontaneous neutrophil apoptosis. Neutrophils were incu-
bated overnight with medium (A) or once-washed tachyzoites that
were resuspended in fresh medium (1:2 neutrophil-to-parasite ratio)
(B), and cytospin preparations were stained with Diff-Quik. Photomi-
crographs were made using Kodak Elite chrome ASA 100 slide film,
and 35-mm slides were scanned into Adobe Photoshop files using a
Polaroid SprintScan 35 (Polaroid Corp., Cambridge, Mass.). Apoptotic
neutrophils are small cells with condensed, darkly staining nuclei (ar-
rows); nonapoptotic cells have multilobed nuclei; some neutrophils are
infected with tachyzoites (arrowheads). Bar 	 2 m. Results are rep-
resentative of cytospins from eight different donors.
FIG. 2. Neutrophil infection and delayed spontaneous neutrophil
apoptosis are dose-dependent responses. Neutrophils were incubated
overnight with once-washed tachyzoites that were resuspended in fresh
medium at various multiplicities of infection, and cytospin prepara-
tions were stained with Diff-Quik. At least 300 cells were examined at
magnification 1,000, and the percentages of apoptotic or infected
neutrophils were enumerated. Each result is reported as the mean 

standard deviation of triplicate samples and are representative of three
donors.
FIG. 3. Kinetics of the expression of Mcl-1 in stimulated neutro-
phils. Neutrophils were incubated for various times with or without
once-washed tachyzoites that were resuspended in fresh medium (1:2
neutrophil-to-parasite ratio). Proteins in whole-cell lysates were sepa-
rated by SDS-PAGE, and Western blots were incubated with anti-
Mcl-1. Each lane represents 5  105 neutrophil cell equivalents. The
results are representative of two experiments.
6050 CHANNON ET AL. INFECT. IMMUN.
pression was undetectable in infected or uninfected neutro-
phils.
Conditioned medium from toxoplasma-infected fibroblasts
delays spontaneous neutrophil apoptosis. Fig. 1 and 2 show
that spontaneous apoptosis was delayed not only in infected
neutrophils but also in uninfected neutrophils following incu-
bation with once-washed, fibroblast-derived tachyzoites, sug-
gesting that a soluble factor(s) may trigger the signals for
delayed apoptosis. This soluble factor could be derived from
contaminating conditioned medium from the infected fibro-
blasts or from products secreted by the parasites themselves.
To determine the source of the soluble factor(s), freshly iso-
lated neutrophils were incubated for 18 h with medium or with
conditioned medium from either infected or uninfected fibro-
blasts and with an equivalent volume of tachyzoites that had
been washed four times and then assayed for apoptosis using
annexin and PI (Fig. 4A and B). Apoptosis occurred in 71% of
the neutrophils incubated overnight with medium, with dilu-
tions of conditioned medium from uninfected fibroblasts, or
with dilutions of washed parasites (Fig. 4C). In contrast, when
incubated with conditioned medium from infected fibroblasts,
only 27% of neutrophils became apoptotic (Fig. 4C). Hence,
conditioned medium from infected fibroblasts is the source of
the soluble factor that triggers the signals for delayed neutro-
phil apoptosis. Four washes, each using 300 times the pelleted
volume of the parasites, were required to remove contaminat-
ing conditioned medium. The supernatant from each of the
washing steps was shown to delay neutrophil apoptosis, with
each successive supernatant having less activity (data not
shown).
Conditioned medium from toxoplasma-infected fibroblasts
up-regulates the surface expression of neutrophil IL-3R, im-
plicating GM-CSF as a mediator of neutrophil survival. Sev-
eral antiapoptotic factors, including GM-CSF, G-CSF, and
IFN-, could rescue neutrophils from apoptosis. GM-CSF is
also known to up-regulate Mcl-1 expression in human neutro-
phils (39). Conditioned medium from uninfected and from
toxoplasma-infected fibroblasts was tested by ELISA. The con-
centration of G-CSF was at least 60-fold that of GM-CSF for
each sample of conditioned medium from infected fibroblasts
(30 
 5 ng of G-CSF/ml versus 482 
 187 pg of GM-CSF/ml),
whereas IFN- was undetectable. In contrast, conditioned me-
dium from uninfected fibroblasts contained negligible amounts
of all three cytokines (1.2 
 1.0 ng of G-CSF/ml; 22 
 8 pg of
GM-CSF/ml). The presence of functional GM-CSF in condi-
tioned medium was tested by a biological assay: the up-regu-
lation of the surface expression of IL-3R on human neutro-
phils (53). Freshly isolated neutrophils were stained to
determine constitutive surface expression of IL-3R (Fig. 5A).
Conditioned medium from uninfected fibroblasts, GM-CSF, or
conditioned medium from infected fibroblasts preincubated
for 1 h at 37°C with isotype control antibodies or with anti-
GM-CSF neutralizing antibodies was then added to freshly
isolated neutrophils. After overnight incubation, neutrophils
were stained and examined by flow cytometry to determine
whether the surface expression of IL-3R was modulated. Nei-
ther freshly isolated neutrophils (Fig. 5A) nor neutrophils in-
cubated overnight with conditioned medium from uninfected
fibroblasts (Fig. 5B) expressed IL-3R. In contrast, after over-
night incubation with either GM-CSF or conditioned medium
FIG. 4. Conditioned medium from toxoplasma-infected fibroblasts
mediates delayed spontaneous neutrophil apoptosis. Neutrophils were
incubated with medium (A), with a 1:4 dilution of conditioned medium
from uninfected fibroblasts, with a 1:4 dilution of conditioned medium
from infected fibroblasts (B), and with a volume of egressed tachyzoites
that had been washed four times, equivalent to a 1:4 dilution of condi-
tioned medium from infected fibroblasts (see Materials and Methods).
On the next day, washed cells were stained with GFP-annexin and PI and
examined by flow cytometry. A gate was set on the neutrophil population
of interest (see top, FSC versus SSC plots), and apoptosis was determined
by dual color analysis of these cells (see bottom dot plots of GFP-annexin
[FL1-H] versus PI [FL2-H]). Numbers show the percentage of cells within
each quadrant. Plots of both FSC versus SSC and FL1-H versus FL2-H
for conditioned medium from uninfected fibroblasts and washed
tachyzoites were identical to that of medium (A). (C) Percent neutrophils
in early apoptosis measured as the percentage of neutrophils in the lower
right quadrant of the FL1-H versus FL2-H plots. Results in panels A and
B are representative of three experiments. Results in panel C are the
means 
 standard deviations for triplicate samples and are also repre-
sentative of three experiments.
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from toxoplasma-infected fibroblasts, 57 and 34% of neutro-
phils expressed low levels of IL-3R (Fig. 5C and D, respec-
tively). Moreover, the increase in IL-3R expression induced
by conditioned medium from toxoplasma-infected fibroblasts
was markedly decreased when anti-GM-CSF neutralizing an-
tibodies were included during the incubation (Fig. 5E) (from
34 to 9%).
G-CSF and GM-CSF in conditioned medium from toxoplas-
ma-infected fibroblasts are additive in mediating delayed
spontaneous neutrophil apoptosis. The previous results sug-
gest that G-CSF and/or GM-CSF in conditioned medium from
toxoplasma-infected fibroblasts may rescue neutrophils from
apoptosis. We then determined the dose response for each
cytokine and for conditioned medium on neutrophil apoptosis.
Neutrophils were incubated for 18 h with serial dilutions of
GM-CSF, G-CSF, or conditioned medium from toxoplasma-
infected fibroblasts, and then apoptosis was determined using
annexin and PI. Figure 6 shows dose-response curves for each
stimulus. The 50% effective dose for G-CSF (300 pg/ml) was
100-fold that for GM-CSF (3 pg/ml). The dilution at the in-
flection point of each curve was approximately 10 pg/ml for
GM-CSF, 850 pg/ml for G-CSF, and a final dilution of between
1:80 and 1:160 for six different samples of conditioned medium
from toxoplasma-infected fibroblasts. The cytokine concentra-
tion for 1:80 dilutions of conditioned media from toxoplasma-
infected fibroblasts was 6.0 
 2.3 pg of GM-CSF/ml and 375 

63 pg of G-CSF/ml (n 	 5). These values are consistent with
the concentrations of recombinant cytokines that resulted in
delayed apoptosis (Fig. 6A, 10 pg/ml; Fig. 6B, 850 pg/ml).
Experiments were then carried out to determine whether
neutralizing antibodies were able to abrogate the effects of
either 10-pg/ml GM-CSF or 850-pg/ml G-CSF, the maximum
cytokine concentrations expected in 1:80 dilutions of condi-
tioned medium from infected fibroblasts. Dilutions of neutral-
izing antibody or isotype control antibody were preincubated
with a saturating dose of cytokines for 1 h and then added to
neutrophils. Neutrophils were incubated for a further 18 h, and
FIG. 5. Cell surface expression of neutrophil IL-3R. Freshly iso-
lated neutrophils were stained with anti-IL-3R or isotype control
antibodies and examined by flow cytometry (A). Neutrophils were also
incubated for 18 h with conditioned medium from uninfected fibro-
blasts (B), 600 pg of GM-CSF/ml (C), or conditioned medium from
infected fibroblasts preincubated for 1 h with 1 g of isotype control
antibody/ml (D) or 1 g of anti-GM-CSF/ml (E) and then stained.
Stained neutrophils were gated for viable cells by forward and side
scatter criteria. Results are expressed as histograms of the fluorescence
intensity of the viable cell population and are representative of two
experiments. . . .., isotype control antibody; ___, anti-IL-3R.
FIG. 6. Neutrophil apoptosis in response to GM-CSF, G-CSF, and conditioned medium from infected fibroblasts. Neutrophils were incubated
with serial dilutions of GM-CSF (A), G-CSF (B), or conditioned medium from infected fibroblasts (C) for 18 h, and then apoptosis was determined
using GFP-annexin and PI. Spontaneous apoptosis, seen using similar dilutions of conditioned medium from uninfected fibroblasts, or medium
alone, is shown as a dotted line. The asterisk denotes the inflection point for each dose response (the maximal effect for the lowest dilution of the
stimulus). Results are representative of two experiments for cytokines and six experiments for conditioned medium from infected fibroblasts.
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apoptosis was determined. The GM-CSF- or G-CSF-induced
delay in spontaneous neutrophil apoptosis was nearly abro-
gated with 1 g of specific neutralizing antibody/ml (Fig. 7A
and B), whereas isotype control antibody was without effect.
We then determined the effect of neutralizing antibodies on
delayed spontaneous neutrophil apoptosis induced by condi-
tioned medium from toxoplasma-infected fibroblasts. Condi-
tioned medium (1:80 dilution) was preincubated with 1 g of
anti-G-CSF and/or anti-GM-CSF or isotype control anti-
body/ml and incubated with neutrophils overnight, and then
neutrophil apoptosis was determined. Anti-G-CSF was more
effective than anti-GM-CSF in neutralizing the delay in spon-
taneous neutrophil apoptosis (Fig. 7C, 71 versus 33% attenu-
ation, respectively). Moreover, a combination of both antibod-
ies was additive and ablated the delay in spontaneous
neutrophil apoptosis. These results show that G-CSF and GM-
CSF in conditioned medium from toxoplasma-infected fibro-
blasts mediate delayed spontaneous neutrophil apoptosis.
Pharmacological inhibitors of Src family tyrosine kinases,
pertussis-sensitive Gi proteins, phosphatidylinositol 3-ki-
nases, and ERKs attenuate the effect of conditioned medium
from infected fibroblasts, consistent with a role for GM-CSF
and G-CSF. The signal transduction pathways leading to de-
layed neutrophil apoptosis were then investigated using phar-
macological inhibitors. Neutrophils were incubated with inhib-
itors before and during exposure to conditioned medium from
infected fibroblasts, a mixture of G-CSF and GM-CSF, or
medium alone, and apoptosis was measured 18 h later. Neu-
trophil apoptosis decreased from 70 (spontaneous apoptosis)
to 11 or 14% when cells were stimulated with conditioned
medium from infected fibroblasts or a mixture of G-CSF and
GM-CSF, respectively (Fig. 8A and B, spontaneous apoptosis
versus no inhibitor). Whereas each inhibitor had no statistically
significant effect on spontaneous apoptosis (Fig. 8C), pertussis
toxin, PP2, PD098059, AG490, and wortmannin had a marked
effect in attenuating the increased neutrophil survival in re-
sponse to each stimulus (Fig. 8A and B). For example, in the
presence of PP2, neutrophil apoptosis was increased from 11 to
37% and from 14 to 38%, respectively, when stimulated with
conditioned medium from infected fibroblasts or by a mixture
of G-CSF and GM-CSF. In contrast, SB203580 had no statis-
tically significant effect. Since the patterns of inhibition were
similar for the two stimuli, these results suggest that the G-CSF
and GM-CSF in conditioned medium from infected fibroblasts
could be responsible for delaying neutrophil apoptosis. These
results also confirm a role for G protein-coupled receptors
(pertussis toxin), Src family tyrosine kinases (PP2), ERKs
(PD098059), Jak2 kinases (AG490), and phosphatidylinositol
3-kinases (wortmannin) in pathways that lead to increased
neutrophil survival.
DISCUSSION
In this study we have demonstrated that G-CSF and GM-
CSF are secreted by toxoplasma-infected human fibroblasts.
This is the first report that G-CSF is released from T. gondii-
infected cells, in this case, human foreskin fibroblasts. In vivo,
circulating G-CSF levels rise promptly as an acute phase re-
sponse in various infectious diseases. This is accompanied by
proliferation of neutrophil precursors in the bone marrow and
an accelerated maturation and release of neutrophils into pe-
ripheral blood, resulting in neutrophilia (14). GM-CSF is an
important regulator of the growth, differentiation, and matu-
ration of neutrophils, monocytes, and dendritic cells (4). That
both GM-CSF and G-CSF play an important role during in-
nate immunity is suggested by studies showing that GM-CSF-
FIG. 7. Effect of anti-GM-CSF and anti-G-CSF neutralizing antibodies on delayed spontaneous apoptosis induced by GM-CSF, G-CSF, or
conditioned medium from infected fibroblasts. Neutralizing or isotype control antibodies were preincubated for 1 h with 10 pg of GM-CSF/ml
(A) or 850 pg of G-CSF/ml (B) and then added to neutrophils. A 1:80 final dilution of conditioned medium from infected fibroblasts (C) was
preincubated with 1 g of neutralizing or isotype control antibodies/ml for 1 h and then added to neutrophils. Neutrophil apoptosis was determined
18 h later by flow-cytometric analysis of staining with GFP-annexin and PI. Spontaneous apoptosis, seen with 1 g of isotype control antibody/ml,
or medium alone, is shown as a dotted line. Asterisk, statistically significant difference (P  0.001) by a one-way analysis of variance test. Results
are reported as the mean 
 standard deviation of triplicate samples and are representative of two experiments for cytokines and four experiments
for conditioned medium from infected fibroblasts.
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and G-CSF-deficient gene-targeted knockout mice are each
markedly susceptible to infection with Listeria monocytogenes
(61). GM-CSF secretion is induced by tachyzoites not only in
fibroblasts (this study) but also in human retinal pigment epi-
thelial cells (40), human monocytes (15), and murine astro-
cytes (22). The human intestinal epithelial cell line, HT-29,
also secretes GM-CSF and G-CSF following toxoplasma infec-
tion (unpublished observations). T. gondii-infected human fi-
broblasts also secrete the neutrophil-eliciting chemokines, IL-8
(CXCL8) and Gro- (CXCL1) (16). Hence, toxoplasma-in-
fected cells secrete chemokines and cytokines that not only
elicit an influx of mature neutrophils into infected tissues but
also stimulate the release of mature neutrophils from the bone
marrow stores to replenish decreased numbers of these cells in
peripheral blood.
Spontaneous neutrophil apoptosis occurs when neutrophils
are incubated overnight in medium (48). We show that G-CSF
and GM-CSF released by tachyzoite-infected fibroblasts delay
spontaneous neutrophil apoptosis for up to 72 h, confirming
previous reports of enhanced neutrophil survival (6, 9, 13). The
concentrations of rhGM-CSF and rhG-CSF that result in en-
hanced neutrophil survival are similar to those measurable in
conditioned medium from toxoplasma-infected fibroblasts. G-
CSF and GM-CSF not only rescue neutrophils from apoptosis
but have also been reported to prime these cells for enhanced
superoxide production, phagocytosis, and antibody-dependent
cellular cytotoxicity (3, 5, 23, 35). We know that tachyzoites are
lysed extracellularly by neutrophils in vitro, especially in the
presence of specific antibody (20). Neutrophils also phagocy-
tose and digest damaged extracellular tachyzoites in vitro (11).
We also show that tachyzoites themselves have no effect on
neutrophil apoptosis. The persistence of effect shown in Fig. 1
FIG. 8. The effect of pharmacological inhibitors of signal transduction pathways on the response of neutrophils to conditioned medium from
infected fibroblasts (A), a mixture of G-CSF and GM-CSF (B), and medium (C). Neutrophils were preincubated with inhibitors for 1 h before and
during the addition of a 1:80 final dilution of conditioned medium from infected fibroblasts, a mixture of 2 ng of G-CSF/ml and 50 pg of
GM-CSF/ml, or medium. Neutrophil apoptosis was determined 18 h later by flow-cytometric analysis of staining with GFP-annexin and PI. Panel
C shows the effect of inhibitors on spontaneous apoptosis (incubation with medium). Spontaneous apoptosis (neutrophils incubated with medium)
is included in panels A and B for comparison. Results are reported as the means
 standard deviations of triplicate samples and are representative
of three donors. Asterisk, no statistically significant difference from no-inhibitor results by a one-way analysis of variance test (P  0.02).
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to 3 is most likely due to contaminating fibroblast-derived
G-CSF and GM-CSF. Others have investigated the effect of
tachyzoites on apoptosis of the human cell lines HL-60 and
U937 (28). In these studies apoptosis was induced with acti-
nomycin D and measured by a DNA fragmentation assay.
Preincubation of cells with once-washed fibroblast-derived
tachyzoites resulted in a 65% reduction of DNA fragmentation
and was interpreted as a parasite-mediated effect. One expla-
nation for their observation may be the effect of contaminating
fibroblast G-CSF and GM-CSF in their studies. The findings in
a previous study (29) from this same group may also be due to
fibroblast-derived G-CSF/GM-CSF contamination, e.g., UV-
treated parasites show the same response as untreated para-
sites, and heat-killed parasites lose their response. Human
fibroblasts are a frequently used source for in vitro-derived
parasites, and inadvertent contamination with host-derived G-
CSF and GM-CSF should be considered.
GM-CSF mediates its antiapoptotic effect by rapidly induc-
ing the antiapoptotic proteins Mcl-1 and A1, members of the
Bcl-2 family (12, 34). We show that Mcl-1 was rapidly induced
following incubation with once-washed fibroblast-derived
tachyzoites. Mcl-1 was also up-regulated in HL-60 and U937
cell lines following incubation with fibroblast-derived
tachyzoites, and this effect was interpreted to be directly par-
asite-mediated (28). Up-regulation of A1 has been reported in
inflammatory peritoneal neutrophils and macrophages follow-
ing intraperitoneal infection of mice with T. gondii (43). This
study found no correlation between A1 induction and the par-
asitized state of the neutrophils or macrophages. It is likely
that A1 is induced by GM-CSF released in the peritoneum
following intraperitoneal infection. Hence, both A1 and Mcl-1
appear to be involved in apoptosis regulation in response to T.
gondii infection.
The effects of G-CSF and GM-CSF in our studies appear to
be mediated via the Src family kinase/Gi protein/phosphatidyl-
inositol 3-kinase pathway, the Src family kinase/Ras/Raf/ERK
pathway, and the Janus kinase/Stat pathway but not via the p38
mitogen-activated kinase pathway. Activation of Src family
tyrosine kinases and ERKs have been reported for the delayed
apoptotic activity of GM-CSF in human neutrophils (18, 56).
In G-CSF-stimulated human neutrophils, phosphatidylinositol
3-kinases and ERKs reportedly activate protein kinase B (17).
Phosphatidylinositol 3-kinases may be activated either by Src
family tyrosine kinases (17) or by Gi protein  subunits (44).
Activated protein kinase B is known to mediate delayed apo-
ptosis in GM-CSF-stimulated human neutrophils (33) and to
translocate to the nucleus and induce mcl-1 and delayed apo-
ptosis in GM-CSF-stimulated TF-1 cells (55). A variety of
toxoplasma-infected cell lines have previously been reported to
resist apoptosis, although a mechanism for this activity was not
described (41). Goebel et al. found that inhibition of mitochon-
drial cytochrome c release and subsequent caspase activation,
as well as down-regulation of poly(ADP-ribose) polymerase
protein levels, was considerably diminished following incuba-
tion of myeloid cell lines with fibroblast-derived tachyzoites
(28), and they suggest that these effects are T. gondii mediated.
Our studies suggest that neutrophils elicited to infected tis-
sues may not be destroyed within 24 h but may survive for up
to 72 h after diapedesis. This can be beneficial and harmful to
the host. A number of studies in vivo show the importance of
neutrophils in toxoplasmosis. For example, Toxoplasma infec-
tion was found to be exacerbated in neutrophil-depleted mice
(7, 49), and neutrophils are thought to account for the ability
of iNOS knockout animals to control acute Toxoplasma infec-
tion (51). Neutrophil depletion in mice at the time of infection
led to the development of lesions in multiple organs, including
the spleen, lung, liver, and brain, and was associated with a
reduction both in absolute numbers of splenocytes and in se-
cretion of IFN-, tumor necrosis factor alpha, and IL-12 by
splenocytes (7). Furthermore, mice could survive if neutrophils
were removed after day 6 of infection. These results suggest
that neutrophils play a crucial role in the first few days of
infection. Neutrophils provide the first line of defense of the
innate immune response against infecting tachyzoites and are
elicited to the site of infection by CXC chemokines secreted by
infected stromal cells (16). G-CSF and GM-CSF, released in
response to tachyzoite infection, stimulate the release of ma-
ture neutrophils and monocytes from bone marrow to replace
those that have trafficked to infected tissue. That this influx of
neutrophils into peripheral blood is important in toxoplasmosis
is suggested by a study using CCR1 knockout mice (31). Al-
though these mice could mount a normal innate immune re-
sponse, they could not immediately replace neutrophils that
had trafficked to infected tissue with mature neutrophils stored
in the bone marrow. As a consequence, tachyzoites became
established and multiplied in many organs, resulting in the
death of the host. Hence, it appears that at least two waves of
neutrophil recruitment may be necessary during the first few
days of infection for a successful immune response against this
parasite.
Human neutrophils secrete several chemokines in response
to T. gondii antigen, including macrophage inflammatory pro-
tein-1 alpha (MIP-1) (CCL3) and MIP-1 (CCL4), chemo-
kines that elicit monocytes, dendritic cells, NK cells, and T cells
(8). Chemokines are crucial regulators of leukocyte trafficking
that first bring together antigen-loaded dendritic cells and
naïve T and B cells in regional lymph nodes to generate an
adaptive immune response and second guide activated T cells
back into infected tissues. For example, MIP-1 and MIP-1
are ligands for CCR5, and ligation of these chemokines with
their receptors has been shown to activate murine dendritic
cells to release IL-12 following T. gondii infection (2). Neutro-
phils are also known to secrete IP-10 (CXCL10), MIG
(CXCL9), and I-TAC (CXCL11), potent chemoattractants for
NK cells and Th1 lymphocytes (10, 25), and MIP-3 (CCL20)
and MIP-3 (CCL19) (50). MIP-3 is a ligand for CCR6 and
attracts immature dendritic cells, memory T cells, and B cells.
MIP-3 binds exclusively to CCR7 and elicits mature dendritic
cells, naïve and TCR-activated effector/memory T cells, and
NK cells. Hence, neutrophils may play a pivotal role in regu-
lating leukocyte recruitment and shaping the immune response
that follows in the infected tissue.
The ability of the host to survive an infection with T. gondii
is dependent on IL-12 orchestrating the development of a Th1
response, especially IFN- secretion (2, 26, 27, 32, 52). Al-
though dendritic cells are thought to be the most important
IL-12-secreting cells during an immune response, IL-12p70
secretion by human dendritic cells in response to tachyzoites
occurs only in the presence of lymphocytes, especially CD154-
expressing lymphocytes (52). In contrast, neutrophils secrete
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IL-12p70 in response to soluble tachyzoite antigen in the ab-
sence of CD154-expressing lymphocytes (8). Dendritic cells are
also thought to be the most important antigen-presenting cells
during an immune response; however, viable tachyzoites infect
human dendritic cells by active penetration and replicate in-
tracellularly rather than being phagocytosed and digested (11).
Since neutrophils lyse extracellular tachyzoites (20), they may
also provide an extracellular reservoir of tachyzoite antigens
for uptake and antigen presentation by dendritic cells. Hence,
the advantages to the host of prolonged neutrophil survival
during acute toxoplasmosis include increased chemokine se-
cretion that directly or indirectly orchestrates the subsequent
antigen-specific immune response, increased IL-12 secretion,
increased microbicidal activity providing a pool of extracellular
antigen for antigen-presenting cells, and increased phagocyto-
sis of damaged extracellular tachyzoites.
In summary, T. gondii induces the secretion of G-CSF and
GM-CSF from human fibroblasts. These cytokines also rescue
neutrophils from spontaneous apoptosis. Regulation of neu-
trophil apoptosis is a key factor for either resolution or per-
sistence of an inflammatory state (24). This enhanced neutro-
phil survival may contribute to the robust proinflammatory
response elicited in the T. gondii-infected host and to shaping
the subsequent antigen-specific immune response.
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